Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Incidence and prevalence of neuromyelitis optica spectrum disorders in Slovakia.
Szilasiová J, Gazda J, Cimprichová A, Cvengrošová A, Donáth V, Fedičová M, Gurčík L, Hančinová V, Jurčaga F, Kahancová E, Kantorová E, Karlík M, Klímová E, Kováčová S, Krastev G, Megová A, Michalík J, Mikula P, Snopeková Ľ, Števková Z. Szilasiová J, et al. Among authors: donath v. Neurol Res. 2022 Jan;44(1):38-46. doi: 10.1080/01616412.2021.1952741. Epub 2021 Jul 14. Neurol Res. 2022. PMID: 34261427
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.
Trojano M, Butzkueven H, Kappos L, Wiendl H, Spelman T, Pellegrini F, Chen Y, Dong Q, Koendgen H, Belachew S; Tysabri® Observational Program (TOP) Investigators. Trojano M, et al. Mult Scler Relat Disord. 2018 Aug;24:11-19. doi: 10.1016/j.msard.2018.04.020. Epub 2018 May 2. Mult Scler Relat Disord. 2018. PMID: 29860197 Free article.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study.
Cibulcik F, Benetin J, Kurca E, Grofik M, Dvorak M, Richter D, Donath V, Kothaj J, Minar M, Valkovic P. Cibulcik F, et al. Among authors: donath v. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):549-552. doi: 10.5507/bp.2016.023. Epub 2016 Apr 21. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. PMID: 27108605 Free article. Clinical Trial.
11 results